These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 24819365)

  • 1. Interactions of some commonly used drugs with human α-thrombin.
    Nair DG; Narayanan SP; Chittalakkottu S
    J Biomol Struct Dyn; 2015; 33(5):1008-15. PubMed ID: 24819365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and anti-thrombotic evaluation of some novel fluorinated thrombin inhibitor derivatives.
    Chen H; Ren Y
    Arch Pharm (Weinheim); 2015 Jun; 348(6):408-20. PubMed ID: 25881141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of inhibitory potency of argatroban toward thrombin by electrophoretically mediated microanalysis.
    Pochet L; Servais AC; Farcas E; Bettonville V; Bouckaert C; Fillet M
    Talanta; 2013 Nov; 116():719-25. PubMed ID: 24148466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitor binding to thrombin: x-ray crystallographic studies.
    Banner DW; Hadváry P
    Adv Exp Med Biol; 1993; 340():27-33. PubMed ID: 8154341
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of Thrombin Inhibitors on Positive Feedback in the Coagulation Cascade.
    Ustinov NB; Zav'yalova EG; Kopylov AM
    Biochemistry (Mosc); 2016 Mar; 81(3):242-8. PubMed ID: 27262193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of two new bifunctional nonsubstrate type thrombin inhibitors complexed with human alpha-thrombin.
    Féthière J; Tsuda Y; Coulombe R; Konishi Y; Cygler M
    Protein Sci; 1996 Jun; 5(6):1174-83. PubMed ID: 8762149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of binding of low-molecular-weight active site inhibitors to human alpha-thrombin.
    Nilsson T; Sjöling-Ericksson A; Deinum J
    J Enzyme Inhib; 1998 Feb; 13(1):11-29. PubMed ID: 9879511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding affinities for sulfonamide inhibitors with human thrombin using Monte Carlo simulations with a linear response method.
    Jones-Hertzog DK; Jorgensen WL
    J Med Chem; 1997 May; 40(10):1539-49. PubMed ID: 9154975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Biological Evaluation of Some New 2,5-Substituted 1-Ethyl-1H-benzoimidazole Fluorinated Derivatives as Direct Thrombin Inhibitors.
    Li M; Ren Y
    Arch Pharm (Weinheim); 2015 May; 348(5):353-65. PubMed ID: 25824648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the synthetic thrombin inhibitor argatroban on fibrin- or clot-incorporated thrombin: comparison with heparin and recombinant Hirudin.
    Berry CN; Girardot C; Lecoffre C; Lunven C
    Thromb Haemost; 1994 Sep; 72(3):381-6. PubMed ID: 7855788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the Differential Activity of Thrombin Inhibitors Using Docking, QSAR, Molecular Dynamics, and MM-GBSA.
    Mena-Ulecia K; Tiznado W; Caballero J
    PLoS One; 2015; 10(11):e0142774. PubMed ID: 26599107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flavonoids inhibit the amidolytic activity of human thrombin.
    Mozzicafreddo M; Cuccioloni M; Eleuteri AM; Fioretti E; Angeletti M
    Biochimie; 2006 Sep; 88(9):1297-306. PubMed ID: 16690199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of monomeric and polymeric conjugates carrying a thrombin inhibitor through an ester bond.
    Noguchi H; Iwata H; Ikada Y
    J Biomed Mater Res; 1998 Mar; 39(4):621-9. PubMed ID: 9492224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel dabigatran derivatives with a fluorine atom at the C-2 position of the terminal benzene ring: Design, synthesis and anticoagulant activity evaluation.
    Yang H; Liu Q; Gao X; Ren Y; Gao Y
    Eur J Med Chem; 2017 Jan; 126():799-809. PubMed ID: 27951488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism and inhibition kinetics of peptide P13 as thrombin inhibitor.
    Chen F; Huang G
    Int J Biol Macromol; 2020 May; 150():1046-1052. PubMed ID: 31743711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide.
    Skordalakes E; Elgendy S; Goodwin CA; Green D; Scully MF; Kakkar VV; Freyssinet JM; Dodson G; Deadman JJ
    Biochemistry; 1998 Oct; 37(41):14420-7. PubMed ID: 9772168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacokinetics of azlocillin and piperacillin in normal adults.
    Colaizzi PA; Polk RE; Poynor WJ; Raffalovich AC; Cefali EA; Beightol LA
    Antimicrob Agents Chemother; 1986 May; 29(5):938-40. PubMed ID: 3729353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bufadienolides from Kalanchoe daigremontiana as thrombin inhibitors-In vitro and in silico study.
    Kolodziejczyk-Czepas J; Sieradzka M; Moniuszko-Szajwaj B; Pecio Ł; Ponczek MB; Nowak P; Stochmal A
    Int J Biol Macromol; 2017 Jun; 99():141-150. PubMed ID: 28223215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational modelling of inhibitor binding to human thrombin.
    Ljungberg KB; Marelius J; Musil D; Svensson P; Norden B; Aqvist J
    Eur J Pharm Sci; 2001 Feb; 12(4):441-6. PubMed ID: 11231110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic studies of azlocillin and piperacillin during late pregnancy.
    Voigt R; Schröder S; Peiker G
    Chemotherapy; 1985; 31(6):417-24. PubMed ID: 3908007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.